The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutations.
Deng J, Hua L, Han T, Tian M, Wang D, Tang H, Sun S, Chen H, Cheng H, Zhang T, Xie Q, Wan L, Zhu H, Gong Y.
Deng J, et al. Among authors: zhang t.
Neurooncol Adv. 2020 Feb 22;2(1):vdz055. doi: 10.1093/noajnl/vdz055. eCollection 2020 Jan-Dec.
Neurooncol Adv. 2020.
PMID: 32642722
Free PMC article.